Derivative exercise or conversion — not an open-market buy.
Traded Feb 5, 2026 · Filed Feb 6, 2026
A board member of Amphenol paid $1.29M out of pocket for Amphenol shares. The Amphenol shares held grew by 8%.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market purchase
Code P — open-market or private purchase
~$1,285,080
Shares × reported transaction price
$1M+
+8.0%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
Not enough history to judge
Confirmed open-market purchases by the same insider in the available history
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
8 days after results of Jan 28, 2026, 83 days before results of Apr 29, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $63.82 on Feb 5, 2026, 116% above its 52-week low and 23% below its high, after a 6% drop over the previous 30 trading days
52-week range $29.55 (Apr 4, 2025) to $83.13 (Jan 27, 2026), 64% of the way up, from 251 adjusted closes. 30 trading days earlier: $67.57 on Dec 22, 2025. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +3.0% | −1.6% | +4.6% |
| 30 days | −6.7% | −2.5% | −4.2% |
| 90 days | −15.1% | +6.5% | −21.6% |
| 180 days | +16.3% | +11.4% | +4.9% |
Past results only. Not a forecast.
Derivative exercise or conversion — not an open-market buy.
The money chief of Amphenol sold $15M of Amphenol shares. Nobody planned it ahead of time.
Derivative exercise or conversion — not an open-market buy.